受强制性开放获取政策约束的文章 - Alireza Poustforoosh了解详情
无法在其他位置公开访问的文章：2 篇
Foretinib, a c-MET receptor tyrosine kinase inhibitor, tackles multidrug resistance in cancer cells by inhibiting ABCB1 and ABCG2 transporters
S Nazari, F Mosaffa, A Poustforoosh, M Mortazavi, L Saso, O Firuzi, ...
Toxicology and Applied Pharmacology 484, 116866, 2024
强制性开放获取政策： UK Medical Research Council
Spiroisatin pyranopyrimide derivatives as receptor tyrosine kinase inhibitors and targeted anticancer agents
A Alipour, P Farhadi, K Mobaraki, P Mardaneh, S Mohammadi, ...
Journal of Molecular Structure, 141576, 2025
强制性开放获取政策： UK Medical Research Council
出版信息和资助信息由计算机程序自动确定